电子处方笺市场规模、份额和成长分析（按产品类型、交付方式、最终用户、使用方法、物质、专业和地区划分）—产业预测（2026-2033 年）

全球电子处方笺市场规模预计在 2024 年达到 46.4 亿美元，从 2025 年的 58.8 亿美元增长到 2033 年的 393.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 26.8%。

处方错误是医疗机构中药物相关併发症的主要原因之一，也是全球医疗专业人员关注的重大议题。虽然这些错误很少致命，但它们会对患者健康造成严重的不良影响，并可能使医疗专业人员承担法律责任。电子处方笺（简称「电子处方」）作为一种创新解决方案应运而生，它允许医疗服务提供者以电子方式开立处方笺并将其发送至药房。与传统方法相比，这项技术不仅透过最大限度地减少药物交互作用和处方错误来提高病患安全，而且还提高了处方流程的效率和成本效益。随着越来越多的医疗机构采用电子处方笺系统，对这种创新方法的需求预计将会成长，从而促进医疗服务品质的提升。

全球电子处方笺市场驱动因素

全球电子处方笺市场的主要驱动力在于提高病人安全并减少可能对健康结果产生严重影响的用药错误。电子处方系统使医疗专业人员能够有效地查看患者的完整病历、用药资讯和诊断结果，有助于做出明智的决策并最大限度地降低用药错误的风险。随着全球用药错误和潜在药物不良反应的发生率持续上升，预计电子处方解决方案的普及速度将进一步加速。人们对准确用药管理重要性的认识不断提高，凸显了医疗保健产业对先进技术系统的需求，最终推动了市场的发展。

全球电子处方笺市场阻碍因素

儘管电子处方笺系统在临床应用中日益普及，但仍存在一些障碍阻碍其广泛推广。其中一个关键挑战是，将电子处方笺系统整合到电子健康记录（EHR）中需要高昂的实施和维护成本，这成为市场成长的主要障碍。高成本使得许多开发中国家难以采用此类技术解决方案。此外，许多新兴市场医疗IT基础设施不足，也降低了有效实施和管理这些先进系统的能力，进一步限制了电子处方笺市场的扩张。

全球电子处方笺市场趋势

由于电子处方笺软体与电子处方笺电子健康记录(EHR) 解决方案的无缝集成，全球电子处方笺市场正经历显着成长。这种整合带来了独立电子处方系统所不具备的诸多优势，例如更便捷地存取临床记录、实验室数据和临床决策支援。透过提供全面的用药史和药房福利讯息，这种互联互通的方式使关键用药数据触手可及，从而降低了处方错误的发生率。此外，政府为促进医疗机构采用整合式 EHR 系统而推出的各项措施也日益受到支持，进一步推动了市场普及，巩固了电子处方笺在提升病患安全和医疗效率方面的重要作用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管环境
• Start-Ups分析
• 专利分析

全球电子处方笺市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 解决方案
  • 整合解决方案
  • 独立解决方案
• 服务
  • 实施服务
  • 支援和维护服务
  • 培训和教育服务

全球电子处方笺市场规模（按交付方式和复合年增长率划分）（2026-2033 年）

• 基于网路的
• 基于云端的
• 本地部署

全球电子处方笺市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊所
• 药局
• 门诊手术中心
• 其他的

全球电子处方笺市场规模（按使用量和复合年增长率划分）（2026-2033 年）

• 手持式
• 基于计算机的设备

全球电子处方笺市场规模（依药品种类及复合年增长率划分）（2026-2033 年）

• 管制物质
• 不受管制的物质

全球电子处方笺市场规模（依专科划分）及复合年增长率（2026-2033 年）

• 肿瘤学
• 运动医学
• 神经病学
• 循环系统
• 其他的

全球电子处方笺市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• CVS Health Corporation（United States）
• Giant Eagle Inc.（United States）
• Lloyds Pharmacy Limited（United Kingdom）
• Rowland Pharmacy（United Kingdom）
• The Kroger Co.（United States）
• Walmart Inc.（United States）
• Cerner Corporation（United States）
• Allscripts Healthcare Solutions, Inc.（United States）
• McKesson Corporation（United States）
• Athenahealth, Inc.（United States）
• Medtronic plc（Ireland）
• Siemens Healthineers AG（Germany）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• IBM Watson Health（United States）
• Oracle Corporation（United States）

结论与建议

Global E-Prescription Market size was valued at USD 4.64 Billion in 2024 and is poised to grow from USD 5.88 Billion in 2025 to USD 39.32 Billion by 2033, growing at a CAGR of 26.8% during the forecast period (2026-2033).

The prevalence of prescription errors, which account for a significant portion of drug-related complications in healthcare settings, poses a major concern for medical professionals globally. Such errors, while rarely fatal, can lead to substantial adverse effects on patient health and entail potential legal repercussions for practitioners. Electronic prescribing (e-prescribing) has emerged as a transformative solution, enabling healthcare providers to electronically generate and transmit prescriptions to pharmacies. This technology not only enhances patient safety by minimizing drug interactions and prescription mistakes but also increases the efficiency and cost-effectiveness of the prescribing process compared to traditional methods. As healthcare facilities increasingly adopt e-prescribing systems, the demand for this innovative approach is expected to grow, driving advancements in quality healthcare delivery.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescription market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global E-Prescription Market Segments Analysis

Global E-Prescription Market is segmented by Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties and region. Based on Product Type, the market is segmented into Solutions and Services. Based on Delivery Mode, the market is segmented into Web-based, Cloud-based and On-premise. Based on End-User, the market is segmented into Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers and Others. Based on Usage Methods, the market is segmented into Handheld and Computer Based Devices. Based on Substances, the market is segmented into Controlled Substances and Non-controlled Substances. Based on Specialties, the market is segmented into Oncology, Sports Medicine, Neurology, Cardiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global E-Prescription Market

The global E-Prescription market is significantly driven by the need to enhance patient safety and reduce medication errors, which can severely impact health outcomes. E-prescribing systems enable healthcare professionals to efficiently access comprehensive patient medical histories, medication details, and diagnoses, thereby facilitating informed decision-making and minimizing the risk of errors. As the incidence of medication mistakes and potential drug side effects continues to increase worldwide, the adoption of e-prescribing solutions is likely to gain momentum. This growing awareness of the importance of accurate medication management reinforces the necessity for advanced technological systems in healthcare, ultimately propelling the market forward.

Restraints in the Global E-Prescription Market

Although the use of e-prescribing systems in clinical environments is on the rise, several barriers hinder their broader adoption. One major issue is the substantial expense associated with implementing and maintaining integrated e-prescription systems within electronic health records (EHR), which poses a significant obstacle to market growth. The elevated costs make it challenging for many developing countries to embrace these technological solutions. Additionally, inadequate healthcare IT infrastructure in numerous emerging markets further restricts the expansion of the e-prescription market, as it diminishes the capacity to effectively implement and manage these advanced systems.

Market Trends of the Global E-Prescription Market

The Global E-Prescription market is witnessing substantial growth driven by the seamless integration of e-prescribing software with Electronic Health Records (EHR) solutions. This integration offers significant advantages, including enhanced access to clinical notes, laboratory data, and clinical decision support, which standalone e-prescription systems lack. By providing comprehensive medication histories and pharmacy benefits information, this interconnected approach ensures that crucial drug data is readily available, reducing the likelihood of prescription errors. Furthermore, the rising support from government initiatives aimed at promoting integrated EHR systems in healthcare facilities contributes to increased market adoption, solidifying e-prescription's critical role in improving patient safety and care efficiency.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Startup Analysis
• Patent Analysis

Global E-Prescription Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Solutions
  • Integrated Solutions
  • Standalone Solutions
• Services
  • Implementation Services
  • Support & Maintenance Services
  • Training & Education Services

Global E-Prescription Market Size by Delivery Mode & CAGR (2026-2033)

• Market Overview
• Web-based
• Cloud-based
• On-premise

Global E-Prescription Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Pharmacies
• Ambulatory Surgical Centers
• Others

Global E-Prescription Market Size by Usage Methods & CAGR (2026-2033)

• Market Overview
• Handheld
• Computer Based Devices

Global E-Prescription Market Size by Substances & CAGR (2026-2033)

• Market Overview
• Controlled Substances
• Non-controlled Substances

Global E-Prescription Market Size by Specialties & CAGR (2026-2033)

• Market Overview
• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

Global E-Prescription Market Size & CAGR (2026-2033)

• North America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • US
  • Canada
• Europe (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CVS Health Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Giant Eagle Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lloyds Pharmacy Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rowland Pharmacy (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Kroger Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walmart Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athenahealth, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Watson Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations